Product Details
Odefsey® Emtricitabine / Rilpivirine / Tenofovir Alafenamide 200 mg - 25 mg - 25 mg Tablet Bottle 30 Tablets
Manufacturer: GILEAD SCIENCES
MFG#: 61958-2101-01
NDC: 61958-2101-01
PID: 350514
Additional Information
| Product Name | Odefsey® Emtricitabine / Rilpivirine / Tenofovir Alafenamide 200 Mg - 25 Mg - 25 Mg Tablet Bottle 30 Tablets |
| Application | Antiretroviral therapy for HIV-1 infection treatment |
| Generic Drug Name | Emtricitabine, Rilpivirine, Tenofovir Alafenamide |
| Mechanism of Action | Emtricitabine and Tenofovir Alafenamide inhibit reverse transcriptase; Rilpivirine inhibits viral replication |
| Dosage Form | Tablet |
| Strength | 200 mg Emtricitabine, 25 mg Rilpivirine, 25 mg Tenofovir Alafenamide |
| Dosing Frequency | Once daily with food |
| Common Side Effects | Headache, diarrhea, nausea, insomnia, fatigue |
| Serious Adverse Effects | Liver problems, depressive disorders, allergic reactions, lactic acidosis, HIV resistance |
| Precautions | Monitor liver function, renal function, and psychiatric conditions |
| Quantity | 30 Tablets |
| Container Type | Bottle |
| Indications | HIV-1 infection treatment in adults and pediatric patients (=35 kg) |
Description
Odefsey® is a fixed-dose combination tablet containing emtricitabine (200 mg), rilpivirine (25 mg), and tenofovir alafenamide (25 mg). This combination is indicated for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg, as part of a comprehensive antiretroviral therapy regimen. Emtricitabine and tenofovir alafenamide are nucleoside reverse transcriptase inhibitors (NRTIs), while rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI).
Each tablet of Odefsey® is film-coated and should be taken once daily with food. The combination of these three drugs provides potent HIV suppression while minimizing the risk of resistance, especially when used in treatment-naïve individuals. It is important to take the medication as prescribed and in combination with other HIV medications to maintain viral suppression.
Common side effects of Odefsey® include headache, diarrhea, nausea, and insomnia. Serious adverse effects can include liver problems, depressive disorders, and the development of resistance to the drugs if not taken as prescribed. Monitoring of liver function and renal health is advised during treatment.
Frequently Asked Questions (FAQs)
The cost of Odefsey® Emtricitabine / Rilpivirine / Tenofovir Alafenamide 200 mg - 25 mg - 25 mg Tablet Bottle 30 Tablets is $available for registerd members only
Odefsey® Emtricitabine / Rilpivirine / Tenofovir Alafenamide 200 mg - 25 mg - 25 mg Tablet Bottle 30 Tablets is manufactured by GILEAD SCIENCES.
You can purchase Odefsey® Emtricitabine / Rilpivirine / Tenofovir Alafenamide 200 mg - 25 mg - 25 mg Tablet Bottle 30 Tablets on our website at https://supplies.pipelinemedical.com/product/detail/odefsey-emtricitabine-rilpivirine-hydrochloride-and-tenofovir-alafenamide-tablet-350514